Sort   by:  
 Page size 
UnknownHeart failure clinical trial enrollment at a rural satellite hospital.
Not available
S-EPMC9647921 | biostudies-literature
UnknownA phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers.
Not available
S-EPMC8101931 | biostudies-literature
UnknownClinical trial enrollment at a rural satellite hospital during COVID-19 pandemic.
Not available
S-EPMC8327540 | biostudies-literature
UnknownRationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study.
Not available
S-EPMC9198622 | biostudies-literature
UnknownInterleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART).
Not available
S-EPMC8575149 | biostudies-literature
UnknownMavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.
Not available
S-EPMC7969143 | biostudies-literature
UnknownEffect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8293025 | biostudies-literature
Sort   by:  
 Page size